Catalent Acquisitions and Exits, 9 Deals Between 2012 and 2019
life science Company

Catalent has acquired 9 companies, including 8 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Catalent’s largest acquisition to date was in 2019, when it acquired Paragon Bioservices for $1.2B. Catalent has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (50%) and medical products (38%).

Join Mergr and gain access to Catalent’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

Catalent, Inc.

14 Schoolhouse Road,
Somerset, New Jersey 08873
United States,
(732) 537 6325
www.catalent.com

Catalent, Inc. is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent, Inc. was established in 2007 and is headquartered in Somerset, New Jersey.

M&A Summary

Buy vs Sell

Year ≤ '14 '15 '16 '17 '18 '19 T
Buy (1.0/yr) # 3 - 2 1 1 1 8
vol $950M $1.2B $2.2B
Sell (0.0/yr) # 1 - - - - - 1
  9

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Sign-up to View
2
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Paragon Bioservices, Inc.
$1.2B (2019-04-15)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Life Science M&A - Last 3 Years

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 395 life science companies that have made at least 1 acquisition, 13 have acquired at least 5 companies, and 2 have acquired more than 10 companies.

The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 23 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Avista Capital Partners with 6 platform acquisitions.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.6K Private Equity Firms
  • 127K M&A Transactions
  • 136K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.